ATG Plus Low-dose PT-Cy for GVHD Prevention

Clinical trial NCT06108739 · TERMINATED

Trial details

NCT number: NCT06108739
Sponsor: Peking University People's Hospital
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2023-11-01
Primary completion: 2024-12-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.